CoChat

Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) for prevention of malaria and adverse birth outcomes can be compromised by parasites-resistance to sulfadoxine–pyrimethamine. This study prospectively evaluated the effectiveness of IPTp-SP in Southeast Tanzania. From January 2017 to May 2019, HIV-negative and malaria-negative (mRDT) pregnant women attending their first antenatal-care visit in the second or third trimester (n = 500) were enrolled to receive monthly IPTp-SP and followed the protocol till delivery. The primary outcome was the prevalence of histopathological placental malaria. Secondary outcomes were anemia, malaria parasites detected during pregnancy and at delivery, adverse birth outcomes (low-birth-weight [LBW], premature birth, fetal anemia, still birth, and spontaneous abortion). Rates of histopathological placental malaria, any parasitemia at delivery (placental, cord or maternal), and any adverse birth outcome were 9.4%, 20.9%, and 26.5%, respectively. Rates of symptomatic malaria and parasitemia during pregnancy were 2.8% and 16%, respectively. Histopathological placental malaria significantly increased the odds of any adverse birth outcomes, particularly LBW. IPTp-SP with more than or equal to three doses significantly improved birth weight and reduced the risk of LBW by 56% compared to <3 SP doses (p = 0.009). IPTp-SP with more than or equal to three doses is still effective in improving birth weight. However, the detection of histopathological placental-malaria in one-tenth and parasitemia in one-fifth of pregnant women reflects the need to optimize the prevention of malaria during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pathogens9030207

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study flow chart.
Figure 1 Study flow chart.CC BY · PubMed Central
Figure 2 Heat map showing detection of any malaria (n = 87) at delivery in placental tissue; placental blood; maternal peripheral blood; and cord blood using microscopy, mRDT, and real-time PCR. Different malaria species detected by real-time PCR are also shown.
Figure 2 Heat map showing detection of any malaria (n = 87) at delivery in placental tissue; placental blood; maternal peripheral blood; and cord blood using microscopy, mRDT, and real-time PCR. Different malaria species detected by real-time PCR are also shown.CC BY · PubMed Central
Figure 3 Hazard proportions for asymptomatic malaria positivity at ANC visits during pregnancy after the first dose of IPTp-SP stratified by gravidity.
Figure 3 Hazard proportions for asymptomatic malaria positivity at ANC visits during pregnancy after the first dose of IPTp-SP stratified by gravidity.CC BY · PubMed Central
Figure 4 Hazard proportions for anemia during pregnancy after the first dose of IPTp-SP stratified by the level of education.
Figure 4 Hazard proportions for anemia during pregnancy after the first dose of IPTp-SP stratified by the level of education.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 25

Metadata

Authors
Mlugu, E. M., Minzi, O., Asghar, M., Färnert, A., Kamuhabwa, A. A. R., & Aklillu, E.
Affiliations
  • Karolinska University Hospital (SE)
  • Muhimbili University of Health and Allied Sciences (TZ)
Corresponding author
Aklillu, Eleni
Venue
Pathogens
Publisher
MDPI AG
Published
2020-03-11
Volume
9
Issue
3
Pages
207
ISSN
2076-0817 (ISSN-L)
OpenAlex
W3010728375
Cited by
25
References
41
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 2
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Styrelsen för Internationellt Utvecklingssamarbete (51170072)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
sulfadoxine-pyrimethamine, intermittent preventive treatment in pregnancy, malaria in pregnancy, adverse birth outcomes, low birth weight, placental malaria, antimalarial drug resistance, parasitemia, fetal anemia, stillbirth, miscarriage, anemia in pregnancy, dose number

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women. https://app.cochat.ai/papers/10.3390/pathogens9030207
The paper
Mlugu, E. M., Minzi, O., Asghar, M., Färnert, A., Kamuhabwa, A. A. R., & Aklillu, E. (2020). Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women. Pathogens. https://doi.org/10.3390/pathogens9030207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.